Journal profile · Multiple
PHAGE-Therapy Applications and Research
ISSN 2641-6530 · eISSN 2641-6549 · Mary Ann Liebert
PHAGE-Therapy Applications and Research: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; 46 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
PHAGE-Therapy Applications and Research is published by Mary Ann Liebert and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bacteriophages and microbial interactions, Bacterial Genetics and Biotechnology and Plant and Fungal Interactions Research, together about 59.4% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bacteriophages and microbial interactionsEnvironmental Science39.5%
- Bacterial Genetics and BiotechnologyBiochemistry, Genetics and Molecular Biology11.4%
- Plant and Fungal Interactions ResearchBiochemistry, Genetics and Molecular Biology8.5%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5.2%
- Evolution and Genetic DynamicsBiochemistry, Genetics and Molecular Biology4.9%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology3.7%
- Genomics and Phylogenetic StudiesBiochemistry, Genetics and Molecular Biology2.8%
- Aquaculture disease management and microbiotaImmunology and Microbiology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Microbiology (medical) | Q3 | 85/147 | 42nd |
| Virology | Q3 | 51/86 | 41st |
| Applied Microbiology and Biotechnology | Q3 | 83/134 | 38th |
| Microbiology | Q3 | 135/194 | 30th |
| Molecular Biology | Q3 | 301/414 | 27th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.46LetPub ·
- SNIP 2026-06
- 0.44LetPub ·
- h-index
- 21OpenAlex ·
- i10-index
- 41OpenAlex ·
- 2-year mean citedness
- 2.05OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 37LetPub ·
Articles by year OpenAlex count · 249 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 29 | 29 | 338 |
| 2025 | 46 | 46 | 503 |
| 2024 | 36 | 36 | 411 |
| 2023 | 30 | 30 | 291 |
| 2022 | 37 | 37 | 183 |
| 2021 | 31 | 31 | 115 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert
- ISSN
- 2641-6530
- Electronic ISSN
- 2641-6549
FAQ
Frequently asked questions about PHAGE-Therapy Applications and Research
What CAS zone is PHAGE-Therapy Applications and Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, PHAGE-Therapy Applications and Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Microbiology / Virology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
Which databases index PHAGE-Therapy Applications and Research?
According to LetPub and DOAJ records, PHAGE-Therapy Applications and Research is indexed in ESCI and Scopus.
Is PHAGE-Therapy Applications and Research open access, and what is the APC?
PHAGE-Therapy Applications and Research is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .